DK2461802T4 - Granulære sammensætninger med styret frigivelse indeholdende mesalazin og fremgangsmåde til fremstilling deraf - Google Patents
Granulære sammensætninger med styret frigivelse indeholdende mesalazin og fremgangsmåde til fremstilling deraf Download PDFInfo
- Publication number
- DK2461802T4 DK2461802T4 DK10752187.4T DK10752187T DK2461802T4 DK 2461802 T4 DK2461802 T4 DK 2461802T4 DK 10752187 T DK10752187 T DK 10752187T DK 2461802 T4 DK2461802 T4 DK 2461802T4
- Authority
- DK
- Denmark
- Prior art keywords
- manufacture
- controlled
- compositions containing
- granular compositions
- release granular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2009A001434A IT1395143B1 (it) | 2009-08-06 | 2009-08-06 | Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento. |
PCT/IB2010/053329 WO2011015964A1 (en) | 2009-08-06 | 2010-07-21 | Controlled-release granular compositions containing mesalazine and process for the manufacture thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
DK2461802T3 DK2461802T3 (da) | 2018-08-20 |
DK2461802T4 true DK2461802T4 (da) | 2022-11-07 |
Family
ID=41582217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10752187.4T DK2461802T4 (da) | 2009-08-06 | 2010-07-21 | Granulære sammensætninger med styret frigivelse indeholdende mesalazin og fremgangsmåde til fremstilling deraf |
Country Status (9)
Country | Link |
---|---|
US (1) | US8916201B2 (da) |
EP (1) | EP2461802B2 (da) |
CA (1) | CA2768425C (da) |
CY (1) | CY1120915T1 (da) |
DK (1) | DK2461802T4 (da) |
ES (1) | ES2683098T5 (da) |
IT (1) | IT1395143B1 (da) |
PT (1) | PT2461802T (da) |
WO (1) | WO2011015964A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140141075A1 (en) | 2012-11-21 | 2014-05-22 | Warner Chilcott Company, Llc | 5-aminosalicylic acid capsule formulation |
CN106413694B (zh) * | 2014-04-17 | 2020-06-30 | 捷亚瑞医药技术(上海)有限公司 | 制备美沙拉嗪组合物的方法以及由该方法制备的美沙拉嗪组合物 |
TR201722852A2 (tr) | 2017-12-29 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Mesalazi̇ni̇n oral farmasöti̇k kompozi̇syonlari |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
JPH072650A (ja) | 1993-06-18 | 1995-01-06 | Tanabe Seiyaku Co Ltd | 放出部位制御型製剤 |
US5686106A (en) | 1995-05-17 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form for colonic delivery |
US5824339A (en) * | 1995-09-08 | 1998-10-20 | Takeda Chemical Industries, Ltd | Effervescent composition and its production |
AU1075997A (en) | 1996-11-15 | 1998-06-10 | Procter & Gamble Company, The | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
IT1318376B1 (it) * | 2000-03-07 | 2003-08-25 | Pharmatec Internat S R L | Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo. |
DE10013029A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
US20070059368A1 (en) * | 2005-05-31 | 2007-03-15 | Cherukuri S R | Modified release formulations of anti-irritability drugs |
US9149439B2 (en) * | 2005-03-21 | 2015-10-06 | Sandoz Ag | Multi-particulate, modified-release composition |
US20090017110A1 (en) * | 2005-05-31 | 2009-01-15 | Capricorn Pharma Inc. | Modified release formulations of anti-irritability drugs |
-
2009
- 2009-08-06 IT ITMI2009A001434A patent/IT1395143B1/it active
-
2010
- 2010-07-21 ES ES10752187T patent/ES2683098T5/es active Active
- 2010-07-21 US US13/388,749 patent/US8916201B2/en active Active
- 2010-07-21 CA CA2768425A patent/CA2768425C/en active Active
- 2010-07-21 WO PCT/IB2010/053329 patent/WO2011015964A1/en active Application Filing
- 2010-07-21 DK DK10752187.4T patent/DK2461802T4/da active
- 2010-07-21 PT PT107521874T patent/PT2461802T/pt unknown
- 2010-07-21 EP EP10752187.4A patent/EP2461802B2/en active Active
-
2018
- 2018-08-28 CY CY181100897T patent/CY1120915T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2683098T5 (es) | 2022-11-18 |
PT2461802T (pt) | 2018-08-08 |
US8916201B2 (en) | 2014-12-23 |
EP2461802B1 (en) | 2018-05-30 |
IT1395143B1 (it) | 2012-09-05 |
ES2683098T3 (es) | 2018-09-25 |
WO2011015964A1 (en) | 2011-02-10 |
ITMI20091434A1 (it) | 2011-02-07 |
CY1120915T1 (el) | 2019-12-11 |
US20120141592A1 (en) | 2012-06-07 |
EP2461802B2 (en) | 2022-08-03 |
CA2768425C (en) | 2018-02-27 |
EP2461802A1 (en) | 2012-06-13 |
CA2768425A1 (en) | 2011-02-10 |
DK2461802T3 (da) | 2018-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2020008I1 (el) | Φαρμακοτεχνικες μορφες διστρωματικου δισκιου | |
DK3795573T3 (da) | Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf | |
DK2512271T3 (da) | Tobaksprodukt og fremgangsmåde til fremstilling deraf | |
DK2593131T3 (da) | Fremgangsmåder og sammensætninger til cns-levering af iduronat-2-sulfatase | |
DK2274008T3 (da) | Sammensætninger og fremgangsmåder til hæmning af PDGFRBETA og VEGF-A | |
DK2602089T3 (da) | Resinform til nanotryk og fremgangsmåde til fremstilling deraf | |
EP2506835A4 (en) | COMPRESSIBLE COATED PHARMACEUTICAL COMPOSITION, TABLETS AND MANUFACTURING METHOD THEREFOR | |
DK2407166T3 (da) | Tablet og granuleret pulver indeholdende 6-fluor-3-hydroxy-2-pyrazin-carboxamid | |
DK2872153T3 (da) | Accellulære pro-tolerogene sammensætninger og fremgangsmåde til fremstilling heraf | |
DK3428148T3 (da) | Aryloazol-2-yl-cyanoethylaminoforbindelser, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf | |
DK2470656T3 (da) | Sammensætning til hæmning af genekspression og anvendelser heraf | |
DK3150240T3 (da) | Systemer og fremgangsmåder til fremføring af terapeutiske midler | |
DK2475372T4 (da) | Fremgangsmåde til fremstilling af micro-RNA og dets terapeutiske anvendelse | |
DK2673262T3 (da) | Fremgangsmåder til fremstilling af quinolinforbindelser og farmaceutiske sammensætninger indeholdende sådanne forbindelser | |
DK2651415T3 (da) | Mave- og tyktarmsformuleringer og fremgangsmåder til fremstilling og brug af dem | |
DK2247736T3 (da) | Majsplanteevent mon87460 og sammensætninger og fremgangsmåder til detektion deraf | |
DK2638186T3 (da) | Fremgangsmåde og sammensætning til forebyggelse af korrosion af metaloverflader | |
DK2632954T4 (da) | Midler og fremgangsmåder til behandling af dlbcl | |
DK2533761T3 (da) | Fremgangsmåder og sammensætninger til fremstilling af aerosoler | |
DK2598500T3 (da) | Sammensætninger og fremgangsmåder til hæmning af jak-reaktionsvejen | |
IL207724A0 (en) | Cns pharmaceutical compositions and methods of use | |
DK2621477T3 (da) | Oral farmaceutisk tablet til kontrolleret afgivelse af mesalazin og fremgangsmåde til opnåelse deraf | |
DK201001186A (da) | Strækbar hue og fremgangsmåde til fremstilling deraf | |
DK2114393T3 (da) | Farmaceutiske sammensætninger omfattende trigonellin og 4-hydroxyisoleucin og fremgangsmåde hertil | |
DK2475649T3 (da) | Indenonderivat og farmaceutisk sammensætning omfattende samme |